15 results
dm2 summary diagnosis inhibitors adrenal pathophysiology signs symptoms agonists dosing dpp4 glp1 insufficiency sglt2 addisons cah congenital disease dka evaluation
Pathophysiology and Effects of Insulin Deficiency #Insulin #Deficiency #DKA #Ketoacidosis #Diabetes #Pathophysiology #Endocrinology
Pathophysiology and Effects ... of Insulin Deficiency ... #Insulin #Deficiency ... #Ketoacidosis #Diabetes ... Pathophysiology #Endocrinology
Clinical Effects of Large and Small Pituitary Tumours Local complications - Headache, Visual field defect, Disconnection hyperprolactinaemia,
Clinical Effects ... Large and Small Pituitary ... , Visual field defect ... #Tumors #Signs ... Symptoms #Diagnosis #Endocrinology
Pituitary Mass Effects - Pathogenesis and Clinical Findings • Pituitary turnors are almost always a benign
Pituitary Mass Effects ... Pituitary adenomas ... Signs / Symptoms ... Hyperprolactinemia • Diabetes ... #SideEffects #endocrinology
Congenital Adrenal Hyperplasia - 21-Hydroxylase Deficiency - Signs and Symptoms • Brain: Androgenization effects, Glucocorticoid effects,
21-Hydroxylase Deficiency ... - Signs and Symptoms ... • Hypothalamic–Pituitary ... #Signs #Symptoms ... #diagnosis #endocrinology
Sulfonylureas - Pharmacology Summary Mechanisms of Action: Binds to the ATP-sensitive potassium channel in pancreatic beta cells,
Sulfonylureas - Pharmacology ... CKD Common Side Effects ... Sulfonylureas #Pharmacology ... #Summary #DM2 #diabetes ... #endocrinology
Metformin Pharmacology Summary Mechanisms of Action: • Suppresses gluconeogenesis by the liver • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... titration • B12 deficiency ... #Metformin #Pharmacology ... #Summary #DM2 #diabetes ... #endocrinology
Feedback Loop: Growth Hormone (GH) Growth Hormone: • Liver -> GHR activates JAK-STAT pathway -> Incr IGF1
activates lipolysis Signs ... Symptoms: • GH deficiency ... #FeedbackLoop #endocrinology ... pathophysiology #pituitary
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... ) Common Side Effects ... • Euglycemic diabetic ... #Summary #DM2 #diabetes ... #endocrinology
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... Side effects include ... SGLT2 #Inhibitors #Pharmacology ... Medications #DM2 #Diabetes ... #Endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Toxicities: • Gl side effects ... Receptor #Agonists #Pharmacology ... #Summary #DM2 #diabetes ... #endocrinology
No results found for "Defects+signs collateral pharmacology endocrinology pituitary diabetes deficiency"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Defects+signs #collateral #pharmacology #endocrinology #pituitary #diabetes #deficiency